MohamedElsayed AhmedSalemMD

Oncology • Charlotte, NC

Physician

Join to view full profile

Dr. Salem is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Salem's full profile

Already have an account?

Office
1021 Morehead Medical Dr
Ste A
Charlotte, NC 28204
Phone+1 980-442-2000

Fax+1 980-442-5867

Education & Training

Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 2011 - 2014
Wright State University Boonshoft School of MedicineFellowship, Hospice and Palliative Medicine, 2009 - 2010
Wright State UniversityResidency, Internal Medicine, 2004 - 2007
University of Alexandria Faculty of MedicineClass of 2000

Certifications & Licensure

NC State Medical License 2008 - 2025
DC State Medical License 2014 - 2018
MD State Medical License 2014 - 2017
MI State Medical License 2011 - 2015
OH State Medical License 2004 - 2014
American Board of Internal Medicine Medical Oncology

Clinical Trials

Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery Start of enrollment: 2017 Mar 24
Active, not recruiting
Phase 2

Publications & Presentations

PubMed

2 citations
Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: ...
Philip A Philip, Vaibhav Sahai, Nathan Bahary, Amit Mahipal, Anup Kasi
Journal of Clinical Oncology. 2024-11-01
4 citations
Differential Responses to Immune Checkpoint Inhibitors are Governed by Diverse Mismatch Repair Gene Alterations.
Moh'd M Khushman, Michael D Toboni, Joanne Xiu, Upender Manne, Alex Farrell
Clinical Cancer Research. 2024-05-01
1 citations
Unveiling Discrepant and Rare Dihydropyrimidine Dehydrogenase (DPYD) Results Using an In-House Genotyping Test: A Case Series.
D Grace Nguyen, Sarah A Morris, Annabel Chen, Donald C Moore, Sarah L Hanson
Journal of the National Comprehensive Cancer Network. 2024-05-01

Authored Content

Precision Medicine, Targeted Therapy, and ZIP Codes: ASCO GI 2021January 2021
ASCO GI 2019: A Multidisciplinary Approach to Providing Optimal Care for GI Cancer PatientsJanuary 2019
ASCO GI 2019: A Multidisciplinary Approach to Providing Optimal Care for GI Cancer PatientsJanuary 2019

Press Mentions

What to Know About Colon CancerAugust 29th, 2020
Subtle Molecular Changes Along the Upper Digestive Tract Could Guide Cancer TherapyJune 26th, 2017
Number of Mutations in a Tumor Varies by Age and Type of CancerMay 17th, 2017
Join now to see all